2013 Year in review: Clinical Development[:de]2013 Year in review: Clinical Development
Average clinical trials Submissions in 2013: Phase I - 314 studies per Quartile, phase II - 233 studies per Quartile, Phase III - 237 studies per Quartile; R&D Spending in Pharma goes down by 5% in 2013 and in Generics jumps by 18%: Major partnership: [...]